Literature DB >> 21178278

Epidermodysplasia verruciformis and susceptibility to HPV.

Tejas Patel1, L Katie Morrison, Peter Rady, Stephen Tyring.   

Abstract

PURPOSE OF REVIEW: Epidermodysplasia verruciformis has been addressed in depth in the recent literature despite its rarity. The disease is characterized by a persistence in human papillomavirus infections and development of cutaneous malignancies, usually happening more frequently and at a younger age than in the general population. Because of the role of immunodeficiency to viral antigens eventually leading to cancer, EV has become a model for understanding a viral role in cutaneous oncogenesis. Susceptibility loci for EV have been mapped and encoded protein functions are becoming better understood. Discoveries of novel mutations and further study of EV-associated HPV serotypes in lesional and nonlesional skin of affected patients and the general population may help generate a cohesive theory regarding the true role of a defective immune barrier in oncogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21178278      PMCID: PMC3835378          DOI: 10.3233/DMA-2010-0733

Source DB:  PubMed          Journal:  Dis Markers        ISSN: 0278-0240            Impact factor:   3.434


  15 in total

1.  Brazilian waxing and human papillomavirus: a case of acquired epidermodysplasia verruciformis.

Authors:  Mark G Kirchhof; Sheila Au
Journal:  CMAJ       Date:  2014-09-02       Impact factor: 8.262

2.  Restricted Recruitment of NK Cells with Impaired Function Is Caused by HPV-Driven Immunosuppressive Microenvironment of Papillomas in Aggressive Juvenile-Onset Recurrent Respiratory Papillomatosis Patients.

Authors:  Wei Wang; Yue Xi; Shilan Li; Xiangjun Liu; Guixiang Wang; Hui Wang; Mengmiao Pei; Jie Zhang; Jingang Gui; Xin Ni
Journal:  J Virol       Date:  2022-09-26       Impact factor: 6.549

3.  Mutations of TMC1 cause deafness by disrupting mechanoelectrical transduction.

Authors:  Hiroshi Nakanishi; Kiyoto Kurima; Yoshiyuki Kawashima; Andrew J Griffith
Journal:  Auris Nasus Larynx       Date:  2014-06-02       Impact factor: 1.863

4.  Detection of human papillomaviruses in paired healthy skin and actinic keratosis by next generation sequencing.

Authors:  Luisa Galati; Rosario Nicola Brancaccio; Alexis Robitaille; Cyrille Cuenin; Fabiola Luzi; Gianna Fiorucci; Maria Vincenza Chiantore; Nadia Marascio; Giovanni Matera; Maria Carla Liberto; Maria Gabriella Donà; Paola Di Bonito; Tarik Gheit; Massimo Tommasino
Journal:  Papillomavirus Res       Date:  2020-03-25

5.  Genetic variations in the epidermodysplasia verruciformis (EVER/TMC) genes, cutaneous human papillomavirus infection and squamous cell carcinoma of the skin.

Authors:  S S Hampras; D E Rollison; M Tommasino; T Gheit; M B Schabath; J L Messina; N A Fenske; B S Cherpelis; V K Sondak; M R Iannacone; M Schmitt; M Pawlita
Journal:  Br J Dermatol       Date:  2015-11-02       Impact factor: 9.302

6.  A misdiagnosed infection mimicking "tree man disease".

Authors:  Jo Anne Lim; Zulrusydi Ismail; Che Noraini Ibrahim; Soon Eu Chong; Wan Noor Hasbee Wan Abdullah
Journal:  PLoS Negl Trop Dis       Date:  2017-06-15

7.  Mixed Bacteriophage MS2-L2 VLPs Elicit Long-Lasting Protective Antibodies against HPV Pseudovirus 51.

Authors:  Rashi Yadav; Lukai Zhai; Nitesh K Kunda; Pavan Muttil; Ebenezer Tumban
Journal:  Viruses       Date:  2021-06-10       Impact factor: 5.048

Review 8.  Laboratory and clinical aspects of human papillomavirus testing.

Authors:  Paul K S Chan; María Alejandra Picconi; Tak Hong Cheung; Lucia Giovannelli; Jong Sup Park
Journal:  Crit Rev Clin Lab Sci       Date:  2012 Jul-Aug       Impact factor: 6.250

9.  EVER2 protein binds TRADD to promote TNF-α-induced apoptosis.

Authors:  G Gaud; D Guillemot; Y Jacob; M Favre; F Vuillier
Journal:  Cell Death Dis       Date:  2013-02-21       Impact factor: 8.469

10.  The transmembrane channel-like protein family and human papillomaviruses: Insights into epidermodysplasia verruciformis and progression to squamous cell carcinoma.

Authors:  Jaime S Horton; Alexander J Stokes
Journal:  Oncoimmunology       Date:  2014-04-15       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.